Independent education

Free access · no login required · commercial relationships clearly labeled

Canada + US

Analytical testing

What does 99% HPLC purity mean?

Usually, it means that the main integrated UV peak accounts for approximately 99% of the included peak area under one method. That is useful information—but much narrower than a complete quality claim.

The simplified calculation

Main-peak area ÷ included peak area × 100

The percentage depends on which peaks are separated, detected, and included by the method and integration rules. It is not automatically a weight-percent assay.

Illustrative example9,900 ÷ (9,900 + 100) × 100 = 99.0%

This example explains arithmetic only. Real chromatograms require defined system suitability, integration, and method controls.

How HPLC-UV works

Four stages create the chromatogram.

  1. 01
    Prepare and inject

    A defined amount of prepared sample enters the instrument. Preparation choices can change what reaches the column.

  2. 02
    Separate

    Components move differently through the column as the mobile phase carries them forward.

  3. 03
    Detect

    The UV detector records absorbance as separated components leave the column.

  4. 04
    Integrate

    Software and analyst rules determine peak boundaries and calculate the areas used in the reported result.

Boundaries

What HPLC-UV does not establish on its own.

Identity

The main peak must still be shown to represent the claimed molecule.

Vial quantity

Relative peak area does not state the total milligrams in the vial.

Sterility

Microbial absence requires a dedicated sterility method.

Endotoxin

Bacterial endotoxin requires a separate, fit-for-purpose test.

All impurities

Some compounds may co-elute, respond weakly, or fall outside the method.

Safety

An analytical result is not a clinical safety or suitability determination.

Method comparability

Why laboratories may report different results.

Sample and preparation
Laboratories may receive different vials or use different storage, dissolution, dilution, filtration, or preparation steps.
Separation and detection
Column, mobile phase, gradient, flow, temperature, run time, wavelength, detector response, and sensitivity affect which components are resolved and detected.
Integration and calculation
Peak boundaries, thresholds, exclusions, manual adjustments, area normalization, reference standards, assay basis, and corrections can change the reported value. Results from two laboratories are not directly comparable until the samples, methods, data handling, and calculation bases are shown to be sufficiently comparable.
Put the number in contextRead the full COA guideCheck a laboratory reportUse the verification workflowCompare test methodsExplore the analytical testing hub

HPLC FAQ

Keep the conclusion proportional to the test.

01Does one large HPLC peak prove peptide identity?

No. Retention behavior and UV response can support a conclusion under a validated method, but identity normally requires suitable comparison or orthogonal evidence. Peak size alone is not molecular identification.

02Can a 99% area-purity sample contain the wrong vial quantity?

Yes. Relative peak area and total analyte quantity are different measurements. A sample can have a dominant main peak while the vial contains more or less material than claimed.

03Why might two laboratories report different purity values?

They may receive different samples or use different preparation, column, mobile phase, gradient, wavelength, detector settings, integration rules, reference standards, or calculation bases. A difference does not explain itself, and the values should not be treated as directly comparable until these conditions are shown to be sufficiently comparable.

04Can HPLC-UV detect every impurity?

No. Detection depends on separation and UV response under the chosen method. Co-eluting compounds, UV-inactive or weakly absorbing components—including many salts or formulation residues—excluded peaks, microorganisms, and endotoxin may require other approaches.

Standards and guidance

No single framework validates every method.

FDA and ICH Q2(R2) and Q14
Official final guidance provides a pharmaceutical framework for analytical-procedure development and validation.
ISO/IEC 17025
Laboratory accreditation addresses competence within a defined scope. An organization-level accreditation claim does not show that a specific peptide HPLC-UV procedure is inside that scope.
Eurachem and method-specific requirements
General fitness-for-purpose guidance, compendial procedures, and method-specific requirements have different roles. They should not be presented as interchangeable.

Official pharmaceutical guidance

Method development and validation matter.

FDA: Q2(R2) and Q14Final analytical procedure guidance ↗

Canadian implementation

Confirm the implemented Canadian guidance.

Health Canada: ICH quality guidelinesCanadian guidance index, including implemented Q2(R2) and Q14 guidance ↗

Laboratory competence

Accreditation is scope-specific.

ISO/IEC 17025:2017General requirements for testing and calibration laboratories ↗